Tenascin-C promotes bladder cancer progression and its action depends on syndecan-4 and involves NF-κB signalling activation

Bladder Cancer (BCa) is a severe genitourinary tract disease with an uncertain pathology. Increasing evidence indicates that the tumor microenvironment plays a decisive role with respect to cancer progression, and that this is driven by tumor cell interactions with stromal components.